Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

NCT00252642 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Cirrhosis
Fibrosis

Interventions

DRUG: Peginterferon Alpha-2a

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]